![Carole Ho](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carole Ho
Directeur/Membre du Conseil chez
ROYALTY PHARMA PLC
Fortune : 12 M $ au 30/06/2026
Profil
Carole Ho, MD, est directrice indépendante de NGM Biopharmaceuticals, Inc. et de Beam Therapeutics, Inc. et directrice médicale et chef du développement de Denali Therapeutics, Inc. Elle est membre du conseil d'administration de NGM Biopharmaceuticals, Inc. et de Beam Therapeutics, Inc. Auparavant, le Dr Ho a occupé le poste de vice-présidente du développement clinique précoce des produits non oncologiques chez Genentech, Inc. et celui de directrice médicale chez Johnson & Johnson. Elle a obtenu son diplôme de premier cycle au Harvard College et un doctorat au Weill Cornell Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
DENALI THERAPEUTICS INC. 0,27 % | 13/08/2025 | 424 804 ( 0,27 % ) | 11 M $ | 30/06/2026 |
| 05/06/2026 | 13 103 ( 0 % ) | 734 685 $ | 30/06/2026 | |
| 04/06/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Carole Ho
| Sociétés | Poste | Début |
|---|---|---|
| ROYALTY PHARMA PLC | Directeur/Membre du Conseil | 17/07/2025 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 06/11/2025 |
Anciens postes connus de Carole Ho
| Sociétés | Poste | Fin |
|---|---|---|
| BEAM THERAPEUTICS INC. | Directeur/Membre du Conseil | 27/02/2026 |
| DENALI THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 06/11/2025 |
| NGM BIOPHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 05/04/2024 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/06/2015 |
| JOHNSON & JOHNSON | Directeur Technique/Scientifique/R&D | 01/10/2007 |
Formation de Carole Ho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
NGM Biopharmaceuticals, Inc.
 NGM Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel & life-changing medicines | Health Technology |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
Beam Therapeutics, Inc.
 Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royalty Pharma Plc
 Royalty Pharma Plc Pharmaceuticals: MajorHealth Technology Buys and operates a portfolio of biopharmaceutical royalties | Health Technology |
